Publications list for Professor Mark Gillies

2013 | 2012 | 2011 | 2010 | 2009 | 2008

2013

   
  • O'Day, R., Gillies, M., Ahlenstiel, G. (2013), Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World Journal of Gastroenterology. 19(45), 8227-8237. [Abstract]
  • Powner, M., Gillies, M., Zhu, M., Vevis, K., Hunyor, A., Fruttiger, M. (2013), Loss of Muller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology. 120(11), 2344-2352. [Abstract]
  • Zhu, M., Krilis, M., Gillies, M. (2013), The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2. Retina. 33(8), 1547-1550. [Abstract]
  • Holz, F., Bandello, F., Gillies, M., Mitchell, P., Osborne, A., Sheidow, T., Souied, E., Figueroa, M. (2013), Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. The British Journal of Ophthalmology. 97(9), 1161-1167. [Abstract]
  • Chung, S., Shen, W., Gillies, M. (2013), Laser Capture Microdissection-Directed Profiling of Glycolytic and mTOR Pathways in Areas of Selectively ablated Muller Cells in the Murine Retina. Investigative Ophthalmology & Visual Science. 54(10), 6578-6585. [Abstract]
  • Zhu, L., Shen, W., Zhu, M., Coorey, N., Nguyen, A., Barthelmes, D., Gillies, M. (2013), Anti-retinal antibodies in patients with Macular Telangiectasia Type 2. Investigative Ophthalmology & Visual Science. 54(8), 5675-5683. [Abstract]
  • Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013), Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical & Experimental Ophthalmology. 41(2), 187-200. [Abstract]
  • Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013), Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical & Experimental Ophthalmology. 41(2), 201-214. [Abstract]
  • Gillies, M., Walton, R., Liong, J., Arnold, J., McAllister, I., Morlet, N., Hunyor, A., Guymer, R., Keeffe, J., Essex, R., Herrera-Bond, A., Glastonbury, B., Simpson, J., Barthelmes, D. (2013), Efficient capture of high-quality data on outcomes of treatment for macular diseases: The Fight Retinal Blindness! Project. Retina. 34(1), 188-195. [Abstract]
  • Gillies, M., Walton, R., Simpson, J., Arnold, J., Guymer, R., McAllister, I., Hunyor, A., Essex, R., Morlet, N., Barthelmes, D. (2013), Prospective Audit of Exudative Age-Related Macular Degeneration: 12-month Outcomes in Treatment-Naive eyes. Investigative Ophthalmology & Visual Science. 54(8), 5754-5760. [Abstract]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Zhu, L., Shen, W. (2013), Isolation and characterization of mouse bone marrow-derived Lin(-)/VEGF-R2 (+) progenitor cells. Annals of Hematology. 92(11), 1461-1472. [Abstract]
  • Zhang, X., Lai, D., Bao, S., Hambly, B., Gillies, M. (2013), Triamcinolone Acetonide Inhibits p38MAPK Activation and Neuronal Apoptosis in Early Diabetic Retinopathy. Current Molecular Medicine. 13(6), 946-958. [Abstract]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Karimipour, M., Zhou, M., Zhu, L., Shen, W. (2013), Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Blood Cells, Molecules & Diseases. 51(3), 163-173. [Abstract]
  • Issa, P., Gillies, M., Chew, E., Bird, A., Heeren, T., Peto, T., Holz, F., Scholl, H. (2013), Macular telangiectasia type 2. Progress in Retinal and Eye Research. 34, 49-77. [Abstract]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Wang, J., Mitchell, P., Ramdas, W., Vingerling, J. (2013), Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3. Ophthalmic Epidemiology. 20(2), 109-113. [Abstract]
  • Zhang, X., Wang, N., Bao, S., Gillies, M. (2013), Diabetic retinopathy: Neuron protection as a therapeutic target. The International Journal of Biochemistry & Cell Biology. 45(7), 1525-1529. [Abstract]
  • Kemp, A., Preen, D., Morlet, N., Clark, A., McAllister, I., Briffa, T., Sanfilippo, F., Ng, J., McKnight, C., Reynolds, W., Gilles, M. (2013), Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: a whole population study. Retina. 33(5), 920-927. [Abstract]
  • O'Day, R., Barthelmes, D., Zhu, M., Wong, T., McAllister, I., Arnold, J., Gillies, M. (2013), Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema. Clinical Ophthalmology (Auckland, N.Z.). 7, 1565-1570. [Abstract]
  • Shen, W., Zhu, L., Lee, S., Chung, S., Gillies, M. (2013), Involvement of NT3 and P75NTR in photoreceptor degeneration following selective Muller cell ablation. Journal of Neuroinflammation. 10, 137. [Abstract]
  • Chung, S., Shen, W., Jayawardana, K., Wang, P., Yang, J., Shackel, N., Gillies, M. (2013), Differential gene expression profiling after conditional muller-cell ablation in a novel transgenic model. Investigative Ophthalmology & Visual Science. 54(3), 2142-2152. [Abstract]

2012

   
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2012), Factors promoting success and influencing complications in laser-induced central vein bypass. Ophthalmology. 119(12), 2579-2586. [Abstract]
  • Shen, W., Fruttiger, M., Zhu, L., Chung, S., Barnett, N., Kirk, J., Lee, S., Coorey, N., Killingsworth, M., Sherman, L., Gillies, M. (2012), Conditional Muller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model. Journal of Neuroscience. 32(45), 15715-15727. [Abstract]
  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012), The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Investigative Ophthalmology & Visual Science. 53(12), 7889-7895. [Abstract]
  • Cherepanoff, S., Killingsworth, M., Zhu, M., Nolan, T., Hunyor, A., Young, S., Hageman, G., Gillies, M. (2012), Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. British Journal of Ophthalmology. 96(11), 1404-1409. [Abstract]
  • Salem, W., Fraser-Bell, S., Gillies, M. (2012), Clinical development of new treatments for diabetic macular oedema. Clinical & Experimental Optometry. 95(3), 297-305. [Abstract]
  • Coorey, N., Shen, W., Chung, S., Zhu, L., Gillies, M. (2012), The role of glia in retinal vascular disease. Clinical & Experimental Optometry. 95(3), 266-281. [Abstract]
  • Jay, N., Gillies, M. (2012), Proteomic analysis of ophthalmic disease. Clinical & Experimental Ophthalmology. 40(7), 755-763. [Abstract]
  • Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fruttiger, M., Gillies, M. (2012), Pilot Application of iTRAQ to the Retinal Disease Macular Telangiectasia. Journal of Proteome Research. 11(2), 537-553. [Abstract]
  • Zhang, X., Chen, M., Gillies, M. (2012), Two isoforms of Flk-1 transcripts in early diabetic rat retinas. Current Eye Research. 37(1), 73-79. [Abstract]
  • Dabirrahmani, D., Becker, S., Hogg, M., Appleyard, R., Baroud, G., Gillies, M. (2012), Mechanical variables affecting balloon kyphoplasty outcome - a finite element study. Computer Methods in Biomechanics and Biomedical Engineering. 15(3), 211-220. [Abstract]
  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012), "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Investigative Ophthalmology & Visual Science. 53(10), 6145-6152. [Abstract]
  • Parmalee, N., Schubert, C., Figueroa, M., Bird, A., Peto, T., Gillies, M., Bernstein, P., Kiryluk, K., Terwilliger, J., Allikmets, R. (2012), Identification of a potential susceptibility locus for macular telangiectasia type 2. PLoS One. 7(8), e24268. [Abstract]

2011

   
  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jiao, J., Li, X., Whitcup, S., Li, J. (2011), Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 118(12), 2453-2460. [Abstract]
  • Powner, M., Scott, A., Zhu, M., Munro, P., Foss, A., Hageman, G., Gillies, M., Fruttiger, M. (2011), Basement membrane changes in capillaries of the ageing human retina. British Journal of Ophthalmology. 95(9), 1316-1322. [Abstract]
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2011), Intravitreal Triamcinolone Prior to Laser Treatment of Diabetic Macular Edema 24-Month Results of a Randomized Controlled Trial. Ophthalmology. 118(5), 866-72. [Abstract]
  • Shen, W., Li, S., Chung, S., Zhu, L., Stayt, J., Su, T., Couraud, P., Romero, I., Weksler, B., Gillies, M. (2011), Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. European journal of cell biology. 90(4), 323-32. [Abstract]
  • Shen, W., Zhang, J., Chung, S., Hu, Y., Ma, Z., Gillies, M. (2011), Submacular DL-alpha-aminoadipic acid eradicates primate photoreceptors but does not affect luteal pigment or the retinal vasculature. Investigative ophthalmology & visual science. 52(1), 119-27. [Abstract]
  • Fraser-Bell, S., Gillies, M. (2011), Retinal conditions - Part 1. Australian Doctor. 22, 27-32.
  • Fraser-Bell, S., Gillies, M. (2011), Retinal conditions - Part 2. Australian Doctor. 29, 25-32.

2010

   
  • Powner, M., Gillies, M., Tretiach, M., Scott, A., Guymer, R., Hageman, G., Fruttiger, M. (2010), Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 117(12), 2407-2416. [Abstract]
  • Kuo, C., Gillies, M., McCluskey, P. (2010), Intraocular Triamcinolone for Giant Cell Arteritis?. Archives of Ophthalmology. , 1633. [Abstract]
  • Szental, J., Baird, P., Richardson, A., Islam, F., Scholl, H., Issa, P., Holz, F., Gillies, M., Guymer, R. (2010), Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2. International Ophthalmology. 30(6), 645-650. [Abstract]
  • Gillies, M., Islam, F., Larsson, J., Pasadhika, S., Gaston, C., Zhu, M., Wong, T. (2010), Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomised clinical trial. Clinical & experimental ophthalmology. 38(6), 605-12. [Abstract]
  • Cherepanoff, S., McMenamin, P., Gillies, M., Kettle, E., Sarks, S. (2010), Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. The British journal of ophthalmology. 94(0), 918-25. [Abstract]
  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jacques, M., Jiao, J., Li, X., Whitcup, S. (2010), Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117(6), 1134-1146.e3. [Abstract]
  • Shen, W., Li, S., Chung, S., Gillies, M. (2010), Retinal vascular changes after glial disruption in rats. Journal of neuroscience research. 88(7), 1485-99. [Abstract]
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2010), Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial. Investigative ophthalmology & visual science. 51(5), 2322-8. [Abstract]
  • Gillies, M. (2010), Bevacizumab in ophthalmology: the controversy moves forward. Clinical & Experimental Ophthalmology. 38, 333-334. [Abstract]
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2010), The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology. 117(5), 954-965. [Abstract]
  • Kuo, C., McCluskey, P., Gillies, M. (2010), Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide. Expert Opinion on Pharmacotherapy. 11(1), 155-166. [Abstract]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M. (2010), Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiology. 17(1), 66-73. [Abstract]
  • Parmalee, N., Schubert, C., Merriam, J., Allikmets, K., Bird, A., Gillies, M., Peto, T., Figueroa, M., Friedlander, M., Fruttiger, M., Greenwood, J., Moss, S., Smith, L., Toomes, C., Inglehearn, C., Allikmets, R. (2010), Analysis of candidate genes for macular telangiectasia type 2. Molecular Vision. 16, 2718-2726. [Abstract]

2009

   
  • Gillies, M., Zhu, M., Chew, E., Barthelmes, D., Hughes, E., Ali, H., Holz, F., Scholl, H., Charbel Issa, P. (2009), Familial Asymptomatic Macular Telangiectasia Type 2. Ophthalmology. 116(12), 2422-9. [Abstract]
  • Zhang, X., Bao, S., Hambly, B., Gillies, M. (2009), Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy. The international journal of biochemistry & cell biology. 41(12), 2368-71. [Abstract]
  • Gillies, M., Simpson, J., Gaston, C., Hunt, G., Ali, H., Zhu, M., Sutter, F. (2009), Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology. 116(11), 2182-2187. [Abstract]
  • Larsson, J., Kifley, A., Zhu, M., Wang, J., Mitchell, P., Sutter, F., Gillies, M. (2009), Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta ophthalmologica. 87(3), 275-80. [Abstract]
  • Gillies, M. (2009), Diabetic macular edema. Ophthalmology. , 595; author reply 596-7. [Abstract]
  • Gillies, M., Simpson, J., Zhu, M., Hunt, G., Ali, H., Gaston, C. (2009), Intravitreal triamcinolone. Ophthalmology. , 591. [Abstract]
  • Tikellis, G., Gillies, M., Guymer, R., McAllister, I., Shaw, J., Wong, T. (2009), Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology. 116(2), 319-323. [Abstract]
  • Kuo, C., Gillies, M. (2009), Role of steroids in the treatment of diabetic macular edema. International Ophthalmology Clinics. 49(2), 121-134. [Abstract]

2008

   
  • Wickremasinghe, S., Rogers, S., Gillies, M., Zhu, M., Wong, T. (2008), Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Investigative ophthalmology & visual science. 49(11), 4707-4711. [Abstract]
  • Barthelmes, D., Sutter, F., Gillies, M. (2008), Differential optical densities of intraretinal spaces. Investigative ophthalmology & visual science. 49(8), 3529-3534. [Abstract]
  • Fischer, M., Fleischhauer, J., Gillies, M., Sutter, F., Helbig, H., Barthelmes, D. (2008), A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Investigative ophthalmology & visual science. 49(8), 3617-3621. [Abstract]
  • Barthelmes, D., Gillies, M., Sutter, F. (2008), Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Investigative Ophthalmology & Visual Science. 49(5), 2156-2162. [Abstract]
  • Zhang, X., Bao, S., Lai, D., Rapkins, R., Gillies, M. (2008), Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier through Differential Regulation of VEGF-A and its Receptors in Early Diabetic Rat Retinas. Diabetes. 57(4), 1026-33. [Abstract]
  • Smith, M., Sakurai, G., Smith, S., Young, A., Melrose, J., Stewart, C., Appleyard, R., Peterson, J., Gillies, R., Dart, A., Sonnabend, D., Little, C. (2008), Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis and rheumatism. 58(4), 1055-1066. [Abstract]
  • Liew, G., Gillies, M., Wang, J. (2008), Fenofibrate and diabetic retinopathy. Lancet. , 721; author reply 722. [Abstract]
  • McGimpsey, S., Gillies, M. (2008), Treatment of macular degeneration--controversy and hope. The British Journal of Ophthalmology. , 436-437. [Abstract]
  • Gillies, M. (2008), Surrogate marker. Ophthalmology. , 416-417; author reply 417. [Abstract]
  • Mitchell, P., Gillies, M., Wang, J. (2008), Author reply. Ophthalmology. , 214.
  • Gillies, M. (2008), The role of intravitreal steroids in the management of diabetic retinopathy. In: Diabetic Retinopathy. (pp.435-448).United States: Humana Press.
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M., MacTel Res, G. (2008), The National Eye Institute Visual Function Questionnaire in the macular telangiectasia (MacTel) project. Investigative Ophthalmology & Visual Science. 49(10), 4340-4346. [Abstract]